相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A multifunctional serine protease primes the malaria parasite for red blood cell invasion
Konstantinos Koussis et al.
EMBO JOURNAL (2009)
The future for blood-stage vaccines against malaria
Jack S. Richards et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness
Danielle I. stanisic et al.
INFECTION AND IMMUNITY (2009)
Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure
Philip Bejon et al.
INFECTION AND IMMUNITY (2009)
A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings
Samuel Mabunda et al.
MALARIA JOURNAL (2009)
Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya
Bernhards R. Ogutu et al.
PLOS ONE (2009)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies
Kristina E. M. Persson et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children
Daniel Dodoo et al.
MALARIA JOURNAL (2008)
Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
Jinhong Hu et al.
PLOS ONE (2008)
Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
Fiona J. McCallum et al.
PLOS ONE (2008)
Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
I. Nebie et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
Elissa Malkin et al.
VACCINE (2008)
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa
Issa Nebie et al.
INFECTION AND IMMUNITY (2008)
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3
Christian Roussilhon et al.
PLOS MEDICINE (2007)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Jan P. Vandenbroucke et al.
ANNALS OF INTERNAL MEDICINE (2007)
Naturally acquired antibodies to polyrnorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3
F. H. A. Osier et al.
PARASITE IMMUNOLOGY (2007)
Profiling the antibody immune response against blood stage malaria vaccine candidates
Julian C. Gray et al.
CLINICAL CHEMISTRY (2007)
Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection
Spencer D. Polley et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya
SD Polley et al.
VACCINE (2006)
Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal
Jean Birame Sarr et al.
MICROBES AND INFECTION (2006)
Invasion of red blood cells by malaria parasites
AF Cowman et al.
CELL (2006)
Cytophilic antibodies to Plasmodium falciparum Glutamate Rich Protein are associated with malaria protection in an area of holoendemic transmission -: art. no. 48
JPA Lusingu et al.
MALARIA JOURNAL (2005)
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya
TW Mwangi et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village
R Perraut et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-119, predicts protection from malaria infection and high-density parasitemia
BA Okech et al.
INFECTION AND IMMUNITY (2004)
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria
SD Polley et al.
VACCINE (2004)
Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites
D Gaur et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-119) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa
CC John et al.
JOURNAL OF IMMUNOLOGY (2004)
Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection
V Meraldi et al.
PARASITE IMMUNOLOGY (2004)
Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria
DR Cavanagh et al.
INFECTION AND IMMUNITY (2004)
Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure
R Perraut et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites
S Dutta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria
WG Metzger et al.
PARASITE IMMUNOLOGY (2003)
Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria
SD Polley et al.
INFECTION AND IMMUNITY (2003)
Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam
L Wang et al.
INFECTION AND IMMUNITY (2001)
Antibodies against merozoite surface protein (MSP)-119 are a major component of the invasion-inhibitory response in individuals immune to malaria
RA O'Donnell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Specificity of the protective antibody response to apical membrane antigen 1
AN Hodder et al.
INFECTION AND IMMUNITY (2001)
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
DMN Okenu et al.
INFECTION AND IMMUNITY (2000)
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses
DJ Conway et al.
NATURE MEDICINE (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria
D Dodoo et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
